drugset / Trial / NCT01227915

Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis

NCT01227915

Phase 3 Unknown 70 enrolled Azidus Brasil
RandomizedParallel-groupSingle-blindTreatment

Summary

The primary objective of this study is to evaluate, through clinical parameters, the comparative efficacy between topical Tobracort ® (tobramycin 0.3% dexamethasone + 1% - Chemistry Lab Union) and TOBRADEX ® (tobramycin 0.3% dexamethasone + 1 % - Alcon Lab), using the percentage of improvement (sustained response rate) at the end of treatment.

Timeline

Start
2011-02
Primary completion
2011-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 1 % Topical
Subject Tobramycin Small molecule 0.3 % Topical